index - Plateforme d’immortalisation MyoLine – CRM

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

87 %

Mots clés

Allele-specific silencing therapy Actin BAF Gel electrophoresis DiPRO1 Eteplirsen Glucocorticoid-induced muscle atrophy Emerin Immortalized dystrophic canine myoblast Differentiation Drisapersen LTβR Developmental biology Adeno-associated viral vector Exon-skipping Insulin Computer software Conjugation Myotube CDNA synthesis Antisense oligonucleotide 3D co-culture Machine learning LRP4 Antisense morpholino Cell Therapy BMD Gene Therapy DsDNA break repair Flavonoid Canine X-linked muscular dystrophy in Japan CXMD J FSHD Myotonic dystrophy CMS Human artificial chromosomes CXCL12 Human Fear response Myogenesis Autophagy Laminographie MT RNA/DNA Editing CRISPR/Cas9 Dominant centronuclear myopathy Expanded repeats Gene network analysis DM1 myoblasts Lamina-associated domain CXCR4 Skeletal muscle Adhesion FoxO Chromatin Bile acid Neuromuscular junction ICU-acquired weakness Duchenne Muscular Dystrophy Fibroblast Allele-specific silencing Folding-defective proteins Becker muscular dystrophy Migration Dystrophin CFTR correctors Glucose Motor neuron Exon Skipping Mdx Lamin A/C nuclei Coculture DMD CTG⋅CAGn repeat Gut microbiota Autophagosome Immortalisation Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS MSCs Gene therapy Exondys 51 ITSN1 Centronuclear myopathy Exon skipping Muscle Alternative splicing Atrial cardiac defects KLF15 Dynamin 2 HDMD/Dmd-null mice Duchenne muscular dystrophy Fibrosis Acetylcholine receptor subunit epsilon CLS Human muscle stem/progenitor cells Endocytosis Cell-penetrating peptide Lymphotoxin-β-receptor DNM2 RNA interference Cell biology Clinical trial candidate screening